Sarah Cannon Research Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Sarah Cannon Research Institute
May 30, 2025, 20:35 | Blog
Ishwaria Subbiah: Fresh From Celebrating Our Little Graduates, Now Off To ASCO 2025
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
May 29, 2025, 16:16 | Blog
From Targeted Therapies to Early Detection, Connect With SCRI at ASCO25 - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Meet the experts shaping the future…
May 24, 2025, 09:52 | Blog
McKesson and Endpoints News Will Host Virtual Panel on Technology and Digital Transformation in Precision Medicine at ASCO 2025
McKesson shared a post on LinkedIn: "Join us and Endpoints News for a virtual panel…
May 22, 2025, 09:14 | Blog
Hans Lee: Excited to Join Sarah Cannon Research Institute as Director of Myeloma Research
Hans Lee, Associate Professor & Director Multiple Myeloma Clinical Research at The University of Texas MD…
May 21, 2025, 12:22 | Blog
Vivek Subbiah: Honored to Work Alongside an Incredible Team of Investigators Dedicated to Ending Cancer
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a…
May 21, 2025, 11:58 | Science
Vivek Subbiah: Designing Clinical Trials for Patients With Rare Cancers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an…
May 17, 2025, 08:12 | Insight
Sarah Cannon Research Institute Announced a Strategic Collaboration with IQVIA to Enhance Oncology Clinical Trials Globally
Sarah Cannon Research Institute shared a post on LinkedIn: "We’re excited to announce a strategic…
May 17, 2025, 02:12 | Blog
Inspiring Journey of the 2024 Yvonne Awardees — A Year of Impact and Leadership
In 2024, the Yvonne Awards honored a remarkable group of oncology leaders across diverse categories—from…
May 12, 2025, 04:22 | Blog
Vivek Subbiah: Big thanks to Zhen Su for sharing impressive data from START001
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
May 11, 2025, 07:58 | Blog
Sarah Cannon Research Institute Honors Nurses for Their Dedication During Oncology Nursing Month
Sarah Cannon Research Institute shared a post on LinkedIn: "This Oncology Nursing Month, we honor…
Apr 29, 2025, 09:16 | Blog
Navneet Majhail: Congratulations to Stephen Strickland for presenting first-in-human results of SENTI-202
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network,…
Apr 28, 2025, 12:17 | Blog
Vivek Subbiah: Exhilarating discussions on new podcast - Immunoverse
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a…
Apr 27, 2025, 16:28 | Opinion
Vivek Subbiah Highlights AACR Enduring Impact Award for Rick Pazdur
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on X: "AACR…
Apr 25, 2025, 18:56 | Blog
Naveen Pemmaraju shares farewell message for Dr. Hans Lee joining Sarah Cannon Research Institute
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Apr 22, 2025, 17:31 | Blog
Vivek Subbiah: It's moments like these that remind me why I do what I do
Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn:…
Apr 20, 2025, 09:19 | Science
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an…
Apr 11, 2025, 06:17 | Blog
Erika Hamilton: Sarah Cannon Research Institute is growing this year
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Apr 5, 2025, 15:16 | Blog
Ishwaria Subbiah: How unprocessed grief may be a major hidden driver of the alarming 59% burnout rate among oncologists
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Apr 2, 2025, 16:22 | Blog
Erika Hamilton: So proud of the contributions from Melissa Johnson and SCRI Oncology Partners here and abroad
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Apr 2, 2025, 03:29 | Blog
Celebrating an Expert in Oncology: Dr. Joyce A. O'Shaughnessy - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Celebrating an Expert in Oncology: Dr.…
Mar 27, 2025, 11:47 | Blog
Join us in our mission to change the future of cancer care - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Join us in our mission to change the…
Mar 11, 2025, 12:26 | Blog
Erika Hamilton: JSMO25 was amazing
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Feb 26, 2025, 06:58 | Blog
Melissa Johnson: SCRI Oncology Partners is hiring
Melissa Johnson, Director of Lung Cancer Research at Sarah Cannon Research Institute, shared a post on…
Feb 23, 2025, 00:38 | Blog
David R. Spigel: Breaking down barriers to make clinical trials more accessible for people facing cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, posted on LinkedIn: "Last…
Feb 8, 2025, 07:41 | Blog
Vivek Subbiah: Excited to arrive at the Baptist Health Miami Cancer Institute Precision Oncology Symposium
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Feb 2, 2025, 18:11 | Blog
Vivek Subbiah: Delighted to host the latest episode of the JAMA Oncology podcast
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Jan 23, 2025, 14:32 | Blog
Erika Hamilton: A true team at Sarah Cannon Research Institute
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Jan 21, 2025, 15:31 | Blog
Vivek Subbiah: Delighted to work with an amazing crew at Sarah Cannon Research Institute
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Jan 16, 2025, 10:07 | Oncologist Near Me
Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology
Welcome to OncoDaily’s special section “Oncologist Near Me”, where we introduce prominent oncologists from around the world. Here,…
Jan 14, 2025, 02:16 | Blog
Navneet Majhail: Great opportunity at Sarah Cannon Transplant and Cellular Therapy Network
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network,…
Jan 12, 2025, 15:23 | Insight
Krish Patel: Multi-center effort of CD19 allo iPSC CAR-NK in B-cell lymphomas
Krish Patel, Director of the Lymphoma Research Program at the Sarah Cannon Research Institute, shared…
Jan 11, 2025, 16:11 | Blog
Ishwaria Subbiah: Your most enduring professional legacy is not your CV
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Jan 11, 2025, 15:03 | Blog
Noelle (Noelle Gillette) Cloven: New Year, New Progress, Advancing Cervical Cancer Care in 2025
Noelle (Noelle Gillette) Cloven, Executive Chair Gynecologic Cancer Committee at Sarah Cannon Research Institute, shared…
Jan 7, 2025, 17:27 | Blog
3 Key Insights for Patients Considering Clinical Trials from Vivek Subbiah - SCRI
Sarah Cannon Research Institute shared a post on LinkedIn: "Clinical trials are carefully planned tests…
Jan 7, 2025, 11:39 | Blog
Sarah Cannon Research Institute Grows Network with Addition of Mary Crowley Cancer Research
Sarah Cannon Research Institute shared on LinkedIn: "We are excited to announce a significant expansion…
Jan 7, 2025, 10:29 | Blog
Vivek Subbiah: Proud to welcome Mary Crowley Cancer Research to SCRI
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 28, 2024, 16:23 | Blog
Sarah Cannon Transplant and Cellular Therapy Network is hiring
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network,…
Dec 20, 2024, 02:13 | Blog
Erika Hamilton: Honored to have been elected to the ASCO Nominating Committee
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 18, 2024, 13:19 | Blog
Celebrating 1 Year of SCRI Oncology Partners
SCRI Oncology Partners shared a post on LinkedIn: “Celebrating 1 Year of SCRI Oncology Partners.…
Dec 15, 2024, 18:36 | Blog
More than 65 abstracts and presentations at the 66th ASH Annual Meeting and Exposition by SCRI
Sarah Cannon Research Institute posted on LinkedIn: "And that’s a wrap for ASH24! A standing…
Dec 15, 2024, 08:06 | Blog
Erika Hamilton: Advancing breast cancer care at SABCS
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 14, 2024, 13:35 | Blog
Arif Kamal: Only 7% of adults with a cancer diagnosis enroll in a therapeutic clinical trial
Arif Kamal, Chief Patient Officer for the American Cancer Society, shared a post on LinkedIn:…
Dec 14, 2024, 01:08 | Blog
Erika Hamilton: Does remote symptom monitoring improve fatigue in MBC?
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 13, 2024, 05:58 | Blog
Erika Hamilton: Risk reducing surgery in young BRCA carriers with a prior Breast Cancer, by Matteo Lambertini
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Dec 12, 2024, 16:27 | Insight
Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 10, 2024, 18:02 | Blog
Welcoming experts at ASH24 - Sarah Cannon Research Institute
Sarah Cannon Research Institute posted the following on LinkedIn: “After a great first day of…
Dec 9, 2024, 16:49 | Insight
Erika Hamilton: ADCs are changing breast cancer care
Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn:…
Dec 8, 2024, 10:37 | Blog
"Meet the Expert" sessions at the 2024 ASH Annual Meeting - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting News for ASH24 Attendees! The…
Dec 5, 2024, 07:37 | Blog
Vivek Subbiah: AI for early cancer detection in Lancet Oncology
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), posted…
Dec 4, 2024, 22:59 | Blog
Vivek Subbiah: Improving observational studies with target trial emulation
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), posted…
Nov 30, 2024, 19:13 | Insight
Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 30, 2024, 15:12 | Insight
Dee Anna Smith: Celebrating Patient - Centered Care with SCRI Physicians
Dee Anna Smith, Chief Executive Officer at Sarah Cannon Research Institute, posted on LinkedIn: “At…
Nov 29, 2024, 11:11 | Blog
Vivek Subbiah: The state of AI in Precision Oncology
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 28, 2024, 12:35 | Blog
David R. Spigel: Putting the Pieces Together - Looking at Lung Cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, shared a post on…
Nov 27, 2024, 13:50 | Insight
Development and phenotype of regulatory T cells
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 26, 2024, 23:03 | Blog
Ishwaria Subbiah: Let's Honor the Dedication of Unsung Heroes During National Family Caregivers Month
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Nov 24, 2024, 02:48 | Blog
Vivek Subbiah: Honored to be named one of the 2024 Clarivate Highly Cited Researchers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Nov 22, 2024, 16:40 | Blog
Voting in the ASCO Election is open until December 3
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Nov 21, 2024, 16:49 | Blog
Vivek Subbiah: Incredible Panel Discussion at the Target Cancer Foundation Think Tank
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 21, 2024, 16:00 | Blog
Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Nov 21, 2024, 09:18 | Positive
Vivek Subbiah: Delighted to welcome Krish Patel as our new lymphoma leader SCRI
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 20, 2024, 19:12 | Blog
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Dr. Robert Jotte, Disease Chair, Lung Cancer…
Nov 18, 2024, 20:51 | Insight
Vivek Subbiah: Redefining pancreatic cancer management with tumor-agnostic precision medicine
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared his…
Nov 15, 2024, 16:13 | Blog
Vivek Subbiah: An enlightening panel discussion on the latest advancements in oncology at SCRI meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 14, 2024, 14:09 | Blog
Vivek Subbiah: Supporting Dr. Petros Grivas for the Nominating Committee in the ASCO Election for 2025
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 13, 2024, 14:55 | Blog
Krish Patel has been appointed as the New Director of Lymphoma Research at SCRI
Sarah Cannon Research Institute (SCRI), a global leader in oncology research and community-based clinical trials,…
Nov 12, 2024, 01:16 | Insight
The role of PDOs as preclinical models in gene editing for guiding personalized treatment
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared an…
Nov 10, 2024, 15:34 | Blog
Erika Hamilton: ASCO25 abstracts are open!
Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared a…
Oct 29, 2024, 17:50 | Blog
Denis Horgan: Taking our cancer campaign to the White House
Denis Horgan, Executive Director from the European Alliance of Personalised Medicine (EAPM), shared on LinkedIn: "Taking…
Oct 26, 2024, 17:15 | Blog
Vivek Subbiah: Welcoming Deepak Bhamidipati to Sarah Cannon Research Institute Early Phase Drug Development Unit
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Oct 26, 2024, 10:40 | Blog
Erika Hamilton: The latest advances and controversial topics in the field of breast and gynecological cancers
Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Oct 23, 2024, 13:33 | Blog
Erika Hamilton: Clinical trials should be the first option in fighting cancer not the last
Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn, adding: ''At Sarah…
Oct 22, 2024, 23:50 | Blog
Why clinical trials are essential to delivering patient-centered care - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "October is Patient-Centered Care Awareness Month.…
Oct 22, 2024, 23:24 | Blog
Deepak Bhamidipati appointed as Assistant Director of Drug Development at SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: ''We are thrilled to welcome…
Oct 20, 2024, 13:40 | Insight
The world’s first patient with sickle cell disease to reach the summit of Kilimanjaro
Sarah Cannon Research Institute shared a post on LinkedIn: “Remember Jimi, one of our amazing…
Oct 18, 2024, 15:35 | Blog
Sarah Cannon Research Institute Partners with BostonGene to integrate molecular testing and informatics platforms
Sarah Cannon Research Institute shared a post by BostonGene on LinkedIn, adding: "We are excited to…
Oct 12, 2024, 12:57 | Blog
Jenna Fischer's recent breast cancer battle inspires a conversation around early detection and stage 1 triple positive breast cancer treatment - SCRI
SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: "Important Update: We hope you had…
Oct 11, 2024, 12:32 | Blog
Erika Hamilton: Reflecting on breast cancer research and the importance of clinical trials
Erika Hamilton posted the following on LinkedIn: “Many of us can recall a time in…
Oct 10, 2024, 15:23 | Blog
Erika Hamilton: The Importance of Mammograms - Early Detection Saves Lives
Erika Hamilton shared a post on LinkedIn: "Many of us can recall a time in our…
Oct 8, 2024, 17:05 | Blog
Vivek Subbiah: Big day for foundational models leading to today's AI
Vivek Subbiah shared about Nobel Prize winners. Read his post on LinkedIn below. "Breaking news.…
Oct 7, 2024, 11:25 | Blog
Jeff Sharman: Reflecting on the incredible progress made in lymphoma research
Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…
Oct 6, 2024, 13:26 | Insight
Vivek Subbiah: Fragmentation in medicine harms patients and hinders research
Vivek Subbiah shared a post on LinkedIn about a recent paper "Fragmentation in medicine harms…
Sep 27, 2024, 16:48 | Blog
Skip Burris: Clinical trials should be the first step in fighting cancer
Sarah Cannon Research Institute shared the following on LinkedIn: “Participation in clinical trials should be…
Sep 26, 2024, 06:57 | Blog
Reflecting on advancing cancer treatment through research and innovation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following on LinkedIn: “Today, on World Cancer Research Day,…
Sep 25, 2024, 12:13 | Insight
World Cancer Research Day 2024: Innovation, Hope, and Progress in the Fight Against Cancer
This year World Cancer Research Day's theme is 'Innovation in Cancer Research Drives Progress Toward…
Sep 17, 2024, 18:36 | Blog
Erika Hamilton: Masterful discussion of ILD with TDXd by Pat LoRusso
Erika Hamilton shared a post on X: "Masterful discussion of ILD with TDXd by Dr.…
Sep 10, 2024, 13:42 | Blog
Vivek Subbiah: A morning walk to support melanoma research
Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 13:41 | Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 1, 2024, 17:03 | Blog
Vivek Subbiah: Our WHY is YOU!
Vivek Subbiah shared a post on LinkedIn: ''Clinical trials, Drug development unit dream team. Yes!…
Sep 1, 2024, 16:26 | Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 31, 2024, 09:08 | Insight
Vivek Subbiah: Our commentary on Precision oncology across the ages
Vivek Subbiah shared on LinkedIn about a recent paper titled "Precision oncology across the ages:…
Aug 29, 2024, 15:47 | Insight
Navneet Majhail: Advances and practical application of precision medicine in oncology
Navneet Majhail shared a post on LinkedIn: "On Sarah Cannon Cancer Network grand rounds today,…
Aug 26, 2024, 10:00 | Insight
Vivek Subbiah: We need to challenge Standard-of-care Paradigms in the Precision Oncology era
Vivek Subbiah shared a post on LinkedIn: "Such a delight to deliver a lecture and join…
Aug 25, 2024, 13:09 | Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 16, 2024, 14:58 | Blog
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X: "Can…
Aug 15, 2024, 14:41 | Insight
Vivek Subbiah: Transforming the fragmented silos of medicine into a wheel of collaboration
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Aug 15, 2024, 13:34 | Blog
Navneet Majhail: New complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on…
Aug 14, 2024, 07:07 | Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah shared on X: "Such a delight to share with in Open Access for…
Aug 14, 2024, 06:17 | Insight
Sumanta K. Pal: Viable solutions to "fragmentation" in medicine
Sumanta K. Pal shared a post by Vivek Subbiah on X: "Wonderful piece in Nature…
All: 250 Posts: 1 - 100
Special Coverage